I could not but help notice your other lectures especially to the Fabians.
Disclosure of your interests as a ratbag or "a well known trouble maker".

It was interesting that when Macquarie Pathology was accused of
inappropriate practice when distributing computers to GPs in NSW it was
simply a commercial decision that electronic distribution was cheaper than
courier-delivered reports.

Those of us who are a bit older remember the phrase "review recommended in
three to six months". This no longer happens perhaps because there is CT,
MRI and Ultrasound not to mention radiographically guided tests etc.

We are now increasingly told that BNP is an accurate way to diagnose
congestive cardiac failure rather than rely on clinical symptoms and signs.
Of course if it is positive you are then into Chest X-rays, Ultrasound, and
sometimes more invasive testing.

Times change. When cimetidine was presented to us it was the cleanest drug
to ever hit the market. Now it is the classical case for drug interactions.

Perhaps we could now advise our patient who need anticoagulation to go to
Sizzlers and get discount while they are fed and anticoagulated at the same
time?


David de Bhal
Virtual Practice

-----Original Message-----
From: [EMAIL PROTECTED] [mailto:[EMAIL PROTECTED]
On Behalf Of Ken Harvey
Sent: Tuesday, March 07, 2006 7:27 AM
To: General Practice Computing Group Talk
Subject: Re: [GPCG_TALK] Increase in Pathology / Radiology ordering

Peter MacIsaac wrote:

>> ... there has  been a steady increase in the cost of radiology 
>> services over recent years.

A related increase in pathology testing has attracted considerable 
attention in the Melbourne Age newspaper over the last few days, see:

http://tinyurl.com/fxq2t

http://tinyurl.com/mekc4

http://tinyurl.com/zbtew

The editorial (The Age 6/3) mentioned that the Federal government had 
commissioned a report to investigate why test volumes are increasing. 
Ironically, many such reports have been commissioned in the past and the 
reasons for increasing test volumes are well known. Some of these are 
justified, for example genuine advances in diagnostic testing, greater 
use of tests to appropriately monitor potentially dangerous treatment 
and an aging (and increasingly obese) population with more chronic disease.

Other causes are more dubious such as "defensive" ordering for perceived 
medico-legal reasons, thoughtless ordering encouraged by computerised 
"tick-box" forms (the paper version of which used to be banned) and 
"vertical integration" of companies owning pathology, radiology, GP 
clinic and hospital businesses (which may stimulate over-ordering to 
increase profit).

However, a major problem identified by previous reports is enormous 
variation in how pathology tests are currently used and lack of clear 
guidance for clinicians as to which tests are most cost-effective for 
investigating or managing particular clinical problems (and how 
frequently monitoring tests should be repeated).

To date, the Federal government has focused on supply-side interventions 
  in an attempt to contain escalating test volumes, reducing pathology 
fees if test target volumes were exceeded. However, clinicians, not 
pathologists, order the tests. Many reports have suggested that the 
Royal Australian College of Pathologist's, "Manual of Use and 
Interpretation of Pathology Tests" (funded by the Federal Government) 
needs much more material on what tests are cost-effective for 
investigating common clinical problems in addition to how much blood or 
urine to collect. Furthermore, targeted education and incentives are 
needed if GPs are to order tests appropriately.  Such programs in New 
Zealand are said to have virtually flat-lined "growth" in pathology 
testing (see below).

For those interested, I have reviewed the history of pathology policy in 
a lecture available at: http://www.medreach.com.au/downloads.htm#Pathology

What do others think about how best to achieve, "best-practice" 
pathology ordering?

Cheers
Ken
-- 
Dr. Ken Harvey
Adjunct Senior Research Fellow
School of Public Health, La Trobe University
http://www.medreach.com.au
VOIP:  +61 (03) 9029 0634; Mobile +61 (04) 1918 1910



-------- Original Message --------
Subject: Re: [Haianz] Doctors to be queried over surge in lab tests
Date: Mon, 06 Mar 2006 06:33:55 +1100
From: Ken Harvey <[EMAIL PROTECTED]>
To: HAIANZ <[EMAIL PROTECTED]>

Les Toop wrote:

 > Without wishing to brag the 200 GTPs in CHCH have held lab expenditure
 > flat for a decade with huge effort into evidence based education..

[snip]

Les, can you tell us more about how you "flat-lined" lab expenditure in
N.Z.?

Cheers
Ken
_______________________________________________
Haianz mailing list
[EMAIL PROTECTED]
https://secure.healthyskepticism.org:8443/mailman/listinfo/haianz


-------- Original Message --------
Subject:        CHCH programme
Date:   Mon, 06 Mar 2006 11:44:54 +1300
From:   Les Toop <[EMAIL PROTECTED]>
To:     Ken Harvey <[EMAIL PROTECTED]>

Same way we did with drugs, a mixture of small group peer led education
programmes, practice visits, case studies, distributing summarised
evidence, utilisation feedback, changed the lab form and importantly
incentivised the GPs by allowing them to decide how the savings are
spent on other patient services (eg subsidised smoking cessation,
subsidised palliative care at home, extended care at home, special
situation benefits, free contraceptive care for under 20s  mammograms
prior to the national programme  etc etc.

It really isn't rocket science, but persuading the funders to allow that
level of autonomy is difficult with those who stand to lose undermine
the process at every opportunity.
Les

Les Toop
Professor of General Practice
Head of Department of Public Health and General Practice
Christchurch School of Medicine and Health Sciences
PO Box 4345
Christchurch, New Zealand
Tel 0064 (0)3 3643604
Fax 0064 (0)3 3643637
_______________________________________________
_______________________________________________
Gpcg_talk mailing list
[email protected]
http://ozdocit.org/cgi-bin/mailman/listinfo/gpcg_talk

-- 
No virus found in this incoming message.
Checked by AVG Free Edition.
Version: 7.1.375 / Virus Database: 268.1.2/274 - Release Date: 3/3/2006
 

-- 
No virus found in this outgoing message.
Checked by AVG Free Edition.
Version: 7.1.375 / Virus Database: 268.1.2/274 - Release Date: 3/3/2006
 


_______________________________________________
Gpcg_talk mailing list
[email protected]
http://ozdocit.org/cgi-bin/mailman/listinfo/gpcg_talk

Reply via email to